UPLOAD Filing
Entera Bio Ltd.
Date: May 23, 2025 · CIK: 0001638097 · Accession: 0000000000-25-005540
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38556
Letter
Re: Entera Bio Ltd. Form 10-K for the fiscal year ended December 31, 2024 File No. 001-38556 Dear Dana Yaacov-Garbeli:
May 23, 2025
Dana Yaacov-Garbeli Chief Financial Officer Entera Bio Ltd. Minrav Building Fifth Floor Jerusalem, Israel 9112002
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 23, 2025 Dana Yaacov-Garbeli Chief Financial Officer Entera Bio Ltd. Minrav Building Fifth Floor Jerusalem, Israel 9112002 Re: Entera Bio Ltd. Form 10-K for the fiscal year ended December 31, 2024 File No. 001-38556 Dear Dana Yaacov-Garbeli: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>